Specialists find a hormone that may improve infertility treatments

12.06.2015


British researchers have identified a human hormone that could be a boon to women who are struggling with infertility. As scientists continue to investigate the effects of the hormone on fertility and IVF treatments, their discoveries could lead directly to higher success rates.

The hormone in question is called kisspeptin. Scientists believe that it may be the catalyst for the production of gonadotropin-releasing hormone. In turn, gonadotropin-releasing hormone boosts the production of two hormones that stimulate ovulation in women and sperm production in men.

Kisspeptin's possible role in human fertility is further evidenced by a 2014 study by Imperial College London, which compared blood levels of kisspeptin in women who successfully carried pregnancies to term and women who miscarried. In women who miscarried, levels of kisspeptin were 60% lower than those found in women who carried their pregnancies to term. Furthermore, kisspeptin may reduce the risk of ovarian hyperstimulation syndrome, a serious condition that sometimes occurs in women undergoing IVF treatments.

Kisspeptin is currently the subject of several ongoing clinical trials. The results gathered by researchers may give the doctors a better understanding of if and how they can use kisspeptin in fertility treatments.

Based on: Independent Online

Read also:
International Reproductive Technologies Support Agency | Donation of oocytes, embryos and sperm
© 2025 – International Reproductive Technologies Support Agency. All rights reserved.